Pharmacological Activation of HMN for OSA Aim 2
Clinical trial NCT03858751 · RECRUITING
Trial details
- NCT number
- NCT03858751
- Sponsor
- Brigham and Women's Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2022-11-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.